| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 42,285 | 52,847 | 56,474 | 50,939 | | Cost of Revenue | 5,474 | 5,686 | 6,372 | 7,011 | | | Gross Profit |
-
| 47,161 | 50,102 | 43,928 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 17,751 | 18,288 | 16,517 | 15,875 | | Non Recurring |
-
| (900) | 900 |
-
| | Others | (2,654) | 9,044 | 3,590 | 5,339 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 20,729 | 29,095 | 22,714 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 21,714 | 20,729 | 29,095 | 22,714 | | Interest Expense | 7,262 | 7,586 | 8,051 | 8,494 | | Income Before Tax | 14,452 | 13,143 | 21,044 | 14,220 | | Income Tax Expense | 3,620 | 3,255 | 6,146 | 3,851 | | Minority Interest | (1,599) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,233 | 9,888 | 14,898 | 10,369 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,233 | 9,888 | 14,898 | 10,369 | | Preferred Stock And Other Adjustments | 1,264 | (511) | (753) |
-
| | | Net Income Applicable To Common Shares | $10,497 | $9,377 | $14,145 | $10,369 |
|
0.03% Nasdaq 
Income Statement
